- 4-Week # shares sold: 27,975
- 12-Week # shares bought: 1
- 12-Week # shares sold: 127,975
- 24-Week # shares bought: 1
- 24-Week # shares sold: 547,847
Jim Cramer says the earnings results we get this week will determine where stocks are headed for the rest of the quarter.
The fluorescence imaging technology company has agreed to sell to Stryker for $11.75 per share.
The medical device maker will pay $701 million for NOVADAQ.